Drugmaker Eli Lilly tops 2Q expectations, raises forecast
Eli Lilly raised its 2019 forecast after a jump in sales from the diabetes treatment Trulicity helped push the drugmaker to a better-than-expected second quarter. Revenue from the…
Eli Lilly raised its 2019 forecast after a jump in sales from the diabetes treatment Trulicity helped push the drugmaker to a better-than-expected second quarter. Revenue from the…
